Evaluation of an autogenous vaccine in cattle against Escherichia coli bearing the CTX-M-14 plasmid.
Enteric bacteria with resistance to third and fourth generation cephalosporin antibiotics, especially Escherichia coli bearing the blaCTX-M gene, have been detected in a wide range of food producing animals. However, commercial vaccines for these organisms are not currently available. An autogenous vaccine was prepared from E. coli bearing the blaCTX-M-14 gene and evaluated as a potential control measure to reduce shedding and dissemination of these organisms in cattle. Calves (n=30) received either an autogenous vaccine prepared from E. coli serotype O33 bearing the blaCTX-M-14 gene or a placebo by intramuscular injection on three separate occasions. Two weeks after the final vaccination, all calves were challenged by oral gavage with the O33 CTX-M-14 strain of E. coli (1×10(10) CFU). Faeces, intestinal mucosa and blood samples were taken for enumeration of total and CTX-M-14 E. coli and for assessment of the humoral immune response. The cumulative number of total E. coli excreted at 7 days post-challenge was significantly (p=0.006) lower in the vaccinated group than the placebo group. However, there was no significant difference in the shedding of either CTX-M-14 E. coli or total E. coli between vaccinated and placebo calves throughout the study period. The systemic immune response to E. coli O33 antigen was tested by ELISA and was significantly higher (p<0.001) in vaccinated than placebo calves. However, there was no significant difference in the mucosal immune response. These findings do not support the use of autogenous vaccination for the control of CTX-M-14 E. coli in calves.
Department of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency (AHVLA) Weybridge, New Haw, Addlestone, Surrey, KT15 3NB, United Kingdom. hannah.reeves@ahvla.gsi.gov.uk
H E
HE
Reeves
S B
SB
Lotz
E
E
Kennedy
L P
LP
Randall
N G
NG
Coldham
R M
RM
La Ragione
D000818:Animals; D054991:Autovaccines / Q000627:therapeutic use*; D057138:Bacterial Shedding; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D018550:Cephalosporin Resistance / Q000235:genetics; D004926:Escherichia coli / Q000235:genetics; D004927:Escherichia coli Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control / Q000662:veterinary*; D022361:Escherichia coli Vaccines / Q000627:therapeutic use*; D005243:Feces / Q000382:microbiology; D010957:Plasmids / Q000235:genetics
D054991:Autovaccines; D022361:Escherichia coli Vaccines